Showing 4 of 4 recruiting trials for “Clear cell adenocarcinoma of the ovary”
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
👨⚕️ Panagiotis Konstantinopoulos, MD, PhD, Dana-Farber Cancer Institute📍 2 sites📅 Started Dec 2024View details ↗
Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
RecruitingNCT06279104 ↗
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →